Press release Communiqué de presse

Share the news     Partagez les nouvelles

Email Facebook LinkedIn Twitter

Press release Communiqué de presse


August 1, 2006 1 August, 2006

Pheromone Builds Scientific Advisory Board: Sertoli Cell Expert Dr. Jannette Dufour to Help Develop Diabetes Product


Kelowna, B.C. -- Pheromone Sciences Corp. ("Pheromone") is pleased to announce that Dr. Jannette Dufour, PhD has joined its Scientific Advisory Board ("SAB") to assist the company with its diabetes product development.

"Because Sertoli cells are a key component of our project, Dr. Dufour's extensive research into these cells significantly enhances our team," stated Dr. David White, Chair of Pheromone's SAB. "Her experience working for the University of Alberta's Clinical Islet Transplant Program [originators of the prominent 'Edmonton Protocol'] will be particularly valuable."

Currently Assistant Professor in the Department of Cell Biology and Biochemistry at Texas Tech University Health Sciences Center in Lubbock Texas, Dr. Dufour's research was instrumental in developing the technology leading to some of the Sertoli cell patents now licensed exclusively to Pheromone. The Company owns the exclusive rights to over 20 patents related to the therapeutic use of Sertoli cells.

About Dr. Dufour In 1999 Dr. Dufour received a PhD in Genetics and Cell Biology from Washington State University, where she first began research on Sertoli cells as a graduate student. She then went on to receive further training as a postdoctoral fellow with Drs. Rajotte and Korbutt with the Islet Transplantation Program at the University of Alberta. While there she received five postdoctoral fellowships to study the use of Sertoli cells as a way to immunoprotect transplanted islets. Dr. Dufour is now an Assistant Professor at Texas Tech University Health Sciences Center where she continues to investigate the immunoprotective properties of Sertoli cells with the goal of developing ways to improve the survival of transplanted islets.

Pheromone Sciences Corp. is a biotechnology research and development company focused on commercializing medical technologies.

ON BEHALF OF THE BOARD

"Dev Randhawa"

Dev Randhawa, CEO

For further information contact: Mr. Phil Morehouse Pheromone Sciences Corp. TEL: (250) 868-8177 FAX: (250) 868-8493